Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs
about
Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse eventsRegional citrate anticoagulation for RRTs in critically ill patients with AKI.Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysisCarbon dioxide dialysis in a swine model utilizing systemic and regional anticoagulation.Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy.Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT).Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.
P2860
Q33783011-6FE6BDB6-7C4B-4A91-8119-8AA0826CFF09Q34629661-5D5C03BD-0F44-42CD-9B8C-36438C6BECCFQ35190273-1E0A1F09-97E8-4232-914B-E88C61AC2394Q36285489-320F4EB5-C82B-4A86-9AC6-E122CAC8FF04Q36470982-5FA0A1A7-49D4-4E62-A797-B1CDE50957F6Q36689162-5665F335-6D0E-4ABD-8840-424E7E0DE0CCQ41196531-81C1B8C9-EF3E-4443-81C5-F58E522FF8A3Q42326548-D0018F38-6A4B-4C95-B6E9-50B35425D682Q51018006-E6FC91A1-A8AF-42C3-B2B9-A1993A38C0C2
P2860
Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@ast
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@en
Continuous venovenous hemodiaf ...... osphate supplementation needs.
@nl
type
label
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@ast
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@en
Continuous venovenous hemodiaf ...... osphate supplementation needs.
@nl
prefLabel
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@ast
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@en
Continuous venovenous hemodiaf ...... osphate supplementation needs.
@nl
P2093
P2860
P50
P356
P1433
P1476
Continuous venovenous hemodiaf ...... hosphate supplementation needs
@en
P2093
Alessandro Pierucci
Elio Vitaliano
Enrico Fiaccadori
Francesca Polistena
Laura Zeppilli
P2860
P2888
P356
10.1186/1471-2369-14-232
P577
2013-10-25T00:00:00Z
P5875
P6179
1028850541